Compare Davita Inc (DVA) vs SS&C Technologies Holdings Inc. Common Stock (SSNC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs SS&C Technologies Holdings Inc. Common Stock — how do they compare? Davita Inc trades at $183.49 (market cap $11.53B), while SS&C Technologies Holdings Inc. Common Stock trades at $83.24 (market cap $19.25B). The key difference: SS&C Technologies Holdings Inc. Common Stock is the larger of the two by market cap, and SS&C Technologies Holdings Inc. Common Stock pays a 1.46% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 114 Days and SS&C Technologies Holdings Inc. Common Stock for 0 Days on average.
| DVA | SSNC | |
|---|---|---|
Market Cap | $11.53B | $19.25B |
Volume | 444,368 | 1,341,767 |
Sector | Health | Technology |
52-Week High | $240.96 | $89.62 |
52-Week Low | $103.87 | $62.05 |
Typical Hold Time | 114 Days | 0 Days |
Enterprise Value | $24.25B | $26.59B |
Dividend Yield | — | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $182.08, up 0.17% with a bullish technical signal and strong institutional backing. The stock shows consistent earnings beats with Q2 2026 EPS of $4.02 exceeding expectations. Revenue growth has been steady from $11.6B in 2022 to $13.64B in 2025, though net margins fluctuated. Recent partnership expansion with Humana for value-based kidney care demonstrates strategic growth initiatives. The stock trades at reasonable valuations with P/E of 15.31 and P/S of 0.9, while maintaining strong profitability metrics including 635.3% ROE.
DVA presents a compelling investment case with analyst consensus price target of $235.67 offering 29% upside potential. The company benefits from demographic tailwinds in healthcare services and Warren Buffett's significant ownership. However, investors face risks from regulatory pressures, debt levels at 65.55% of assets, and margin compression concerns highlighted in recent earnings. The stock's technical position near key support at $181 requires monitoring for sustained bullish momentum.
SSNC trades at $81.52, up 0.65% on the day, with a neutral technical signal. The company has consistently beaten earnings estimates in recent quarters (Q4 2025, Q1 2026, Q2 2026) and shows solid fundamentals, including a 13.16% net income margin and 12.73% ROE. Recent news highlights new client wins and AI-driven product enhancements, reinforcing its market position.
The outlook is positive, supported by strong analyst consensus (70.83% Buy rating) and a $91.50 price target, implying ~12% upside. Key risks include execution of growth initiatives and competitive pressures in the financial technology sector. The stock presents a compelling opportunity for investors seeking a fundamentally sound company with recurring revenue streams.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About SS&C Technologies Holdings Inc. Common Stock
SS&C Technologies Holdings, Inc. provides software and outsourced services for financial services and healthcare organizations, covering fund accounting, portfolio management, trading support, and regulatory reporting, and operates as a hedge fund and private equity administrator and mutual fund transfer agent.
Read more on SSNC →
